Searched for
INSULIN MARKET INDIA
The hidden cost of looking better: What health insurance covers, and what it leaves you to payRising demand for weight-loss drugs, cosmetic procedures and wellness treatments is creating a growing out-of-pocket healthcare expense cat...15 Jun, 2026, 11.08 AM IST- Cipla is aiming for 40-50 global product filings in three years, says MD Achin GuptaCipla is charting its next growth phase with a strong focus on innovation, complex generics, and biosimilars. The company plans significant...29 May, 2026, 05.30 AM IST
- Innovation, biosimilars, complex generics to drive Cipla's growth: Achin Gupta, MD & Group CEOAs Cipla approaches its centenary, the company is redefining its strategy by prioritizing innovation to amplify revenues. With ambitions to...29 May, 2026, 12.57 AM IST
- The alchemist of Bengaluru: Kiran Mazumdar-Shaw began from a garageKiran Mazumdar-Shaw has named her niece Claire Mazumdar as successor, setting up a gradual leadership transition at Biocon. A pioneer who b...05 May, 2026, 05.35 PM IST
- Domestic drug companies in a sweet spot as global players look beyond insulinIndian drug cos are increasing their presence in the insulin market. They are competing with multinational corporations. Affordable insulin...20 May, 2025, 12.36 PM IST
- Novo Nordisk to discontinue Human Mixtard, India's largest selling insulin brandNovo Nordisk will discontinue Human Mixtard, a top-selling insulin in India. This decision aligns with the company's global strategy. They ...22 Apr, 2025, 11.50 AM IST
- Weekly-once insulin jab may soon come to IndiaA new weekly insulin dosage by Novo Nordisk, Insulin Icodec, is on the brink of approval in India, offering potential relief for those who ...03 Jul, 2024, 08.20 AM IST
- Eris enters JV with MJ Pharma to commercialise insulins in domestic marketThe business of the joint venture will be kickstarted with the launch of human insulin in the fourth quarter of FY22.03 Dec, 2021, 07.55 PM IST
- Biocon eyes $30b US insulin market via its biosimilarsWith the approval of aspart, Biocon says it will become the first company to receive approvals for two interchangeable insulin drugs in the...25 Oct, 2021, 08.09 AM IST
- Biocon links with Mexico's PiSA to tap US insulin marketBiocon said it has entered into a co-development and commercialization alliance with PiSA of Mexico for recombinant human insulin aimed at ...17 Mar, 2016, 04.40 PM IST
- Novo Nordisk to launch insulin injection Tresiba in IndiaInsulin player Novo Nordisk said it is launching long-lasting insulin injection Tresiba in the country soon.02 Sep, 2013, 05.49 PM IST
- Novo to launch anti-diabetes drug in India by 2010Danish pharmaceutical company Novo Nordisk plans to launch its anti-diabetes drug Liraglutide in India by 2010. The company claims that the...31 Dec, 2008, 03.16 AM IST
- Sanofi-Aventis to shore up diabetes bizEurope’s largest pharma company Sanofi-Aventis has decided to shore up its diabetes business in India08 May, 2008, 02.18 AM IST
- Biocon to launch oral insulin drug by 2010Biotech company Biocon is planning to launch its oral insulin drug in India by 2010 and is targeting sales of Rs 500 crore from the domesti...06 Dec, 2007, 02.24 AM IST
- Biocon to launch oral insulin drug by 2010Biotech company Biocon is planning to launch its oral insulin drug in India by 2010 and is targeting sales of Rs 500 crore from the domesti...06 Dec, 2007, 12.23 AM IST
- Danish drug co Novo Nordisk to set up data centreNovo Nordisk, a speciality pharma company with global leadership in the diabetes care market, has decided to set up its global data managem...15 Sep, 2007, 04.42 AM IST
- India fast emerging as data management hubNovo Nordisk, a speciality pharma company with global leadership in the diabetes care market, has decided to set up its global data managem...14 Sep, 2007, 04.34 AM IST
Load More
